LOXL1
Reaktivität: Human
WB, IF
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Buffer
In 1x PBS, pH 7.4
Handhabung
Aliquot to avoid repeated freezing and thawing.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Aung, Ozaki, Mizoguchi, Allingham, Li, Haripriya, Nakano, Uebe, Harder, Chan, Lee, Burdon, Astakhov, Abu-Amero, Zenteno, Nilgün, Zarnowski, Pakravan, Safieh, Jia, Wang, Williams, Paoli, Schlottmann et al.: "A common variant mapping to CACNA1A is associated with susceptibility to exfoliation syndrome. ..." in: Nature genetics, Vol. 47, Issue 4, pp. 387-92, (2015) (PubMed).
Schlötzer-Schrehardt, Hammer, Krysta, Hofmann-Rummelt, Pasutto, Sasaki, Kruse, Zenkel: "LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma." in: Ophthalmology, Vol. 119, Issue 9, pp. 1832-43, (2012) (PubMed).